371 related articles for article (PubMed ID: 21931380)
1. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T
Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
[TBL] [Abstract][Full Text] [Related]
2. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
3. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
4. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
[TBL] [Abstract][Full Text] [Related]
5. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
6. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
7. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
9. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
11. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
Barbara G
Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
[TBL] [Abstract][Full Text] [Related]
12. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations.
Tobin MC; Moparty B; Farhadi A; DeMeo MT; Bansal PJ; Keshavarzian A
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):49-53. PubMed ID: 18254482
[TBL] [Abstract][Full Text] [Related]
13. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
14. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
[TBL] [Abstract][Full Text] [Related]
15. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G
Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879
[TBL] [Abstract][Full Text] [Related]
16. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
Willot S; Gauthier C; Patey N; Faure C
Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
[TBL] [Abstract][Full Text] [Related]
18. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
[TBL] [Abstract][Full Text] [Related]
19. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
[TBL] [Abstract][Full Text] [Related]
20. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L
Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]